Edition:
United States

People: Emergent BioSolutions Inc (EBS)

EBS on New York Consolidated

30.39USD
17 Feb 2017
Change (% chg)

$-0.54 (-1.75%)
Prev Close
$30.93
Open
$30.77
Day's High
$30.81
Day's Low
$29.65
Volume
248,407
Avg. Vol
460,844
52-wk High
$44.38
52-wk Low
$24.47

Kramer, Robert 

Mr.Robert G. Kramer Sr., is Executive Vice President - Corporate Services Division, Chief Financial Officer and Treasurer of Emergent BioSolutions Inc. He is responsible for finance and administration, IT, investor relations, quality, regulatory affairs and medical affairs. Mr. Kramer first joined Emergent in 1999 as its chief financial officer. From 1999 until his retirement in 2010, he held various executive positions with the last being president of Emergent Biodefense Operations Lansing. Mr. Kramer returned to the company in 2011 as the interim head of the biosciences division, and then as interim executive vice president, corporate services division before taking his current position. Prior to joining Emergent in 1999, Mr. Kramer held various financial management positions at Pharmacia Corporation, which subsequently merged with the Upjohn Company in 1995 and eventually became part of Pfizer Inc. Mr. Kramer received an M.B.A. from Western Kentucky University and a B.S. in industrial management from Clemson University.

Basic Compensation

Total Annual Compensation, USD 751,137
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 760,842
Fiscal Year Total, USD 1,511,980

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Fuad El-Hibri

2,726,910

Daniel Abdun-Nabi

3,642,930

Robert Kramer

1,511,980

Adam Havey

1,073,360

Ronald Richard

427,566

Kathryn Zoon

--
As Of  30 Dec 2015